Optomed Oyj (OPTOMED.HE)
EUR 3.81
(2.7%)
EUR 3.81
(2.7%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.97 Million EUR | 14.92% |
| 2022 | -4.67 Million EUR | -6.84% |
| 2021 | -4.37 Million EUR | -59.27% |
| 2020 | -2.74 Million EUR | -24.21% |
| 2019 | -2.21 Million EUR | -232.33% |
| 2018 | -665 Thousand EUR | 76.48% |
| 2017 | -2.82 Million EUR | -8.27% |
| 2016 | -2.61 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.19 Million EUR | 9.63% |
| 2024 Q2 | -1.87 Million EUR | -56.8% |
| 2023 Q2 | -1 Million EUR | 3.26% |
| 2023 FY | -3.97 Million EUR | 14.92% |
| 2023 Q4 | -1.31 Million EUR | -118.74% |
| 2023 Q3 | -603 Thousand EUR | 40.24% |
| 2023 Q1 | -1.04 Million EUR | -20.02% |
| 2022 Q3 | -1.26 Million EUR | 6.43% |
| 2022 Q4 | -869 Thousand EUR | 31.41% |
| 2022 Q2 | -1.35 Million EUR | 7.39% |
| 2022 Q1 | -1.46 Million EUR | 33.0% |
| 2022 FY | -4.67 Million EUR | -6.84% |
| 2021 FY | -4.37 Million EUR | -59.27% |
| 2021 Q1 | -851 Thousand EUR | -43.27% |
| 2021 Q2 | -859 Thousand EUR | -0.94% |
| 2021 Q4 | -2.18 Million EUR | -145.72% |
| 2021 Q3 | -888 Thousand EUR | -3.38% |
| 2020 Q4 | -594 Thousand EUR | -113.67% |
| 2020 Q2 | -973 Thousand EUR | 8.29% |
| 2020 Q3 | -278 Thousand EUR | 71.43% |
| 2020 FY | -2.74 Million EUR | -24.21% |
| 2020 Q1 | -1.06 Million EUR | -3115.15% |
| 2019 Q3 | -1.1 Million EUR | -40.56% |
| 2019 FY | -2.21 Million EUR | -232.33% |
| 2019 Q4 | -33 Thousand EUR | 97.02% |
| 2019 Q1 | -664 Thousand EUR | -246.58% |
| 2019 Q2 | -789 Thousand EUR | -18.83% |
| 2018 Q3 | -337 Thousand EUR | 0.0% |
| 2018 Q4 | 453 Thousand EUR | 234.42% |
| 2018 FY | -665 Thousand EUR | 76.48% |
| 2017 FY | -2.82 Million EUR | -8.27% |
| 2016 FY | -2.61 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|